Ozop Competitors

Pink Sheets . USA . 
Stock . Ozop Surgical Corp
OZSC Stock  USD 0.0008  0.0001  11.11%   
Ozop Surgical Corp competes with Plug Power, Bloom Energy, Microvast Holdings, Solid Power, and CBAK Energy; as well as few others. The company conducts business under Industrials sector and is part of Electrical Equipment & Parts industry. Analyzing Ozop Surgical competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Ozop Surgical to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Ozop Surgical Correlation with its peers.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Ozop Surgical competition on your existing holdings.
  
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ozop Surgical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.00097.19
Details
Intrinsic
Valuation
LowRealHigh
0.000.00087.19
Details
Naive
Forecast
LowNextHigh
0.0000160.00087.19
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.00090.00090.0009
Details

Ozop Surgical Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Ozop Surgical and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of Ozop and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Ozop Surgical Corp does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
MVST
+ 0.82
BE
FREY
+ 0.81
BE
IPWR
+ 0.75
SLDP
XPON
+ 0.73
SLDP
FREY
+ 0.72
MVST
XPON
+ 0.56
IPWR
  
High negative correlations   
XPON
- 0.78
PPSI
IPWR
- 0.74
BE
PPSI
- 0.72
SLDP
FREY
- 0.68
SLDP
FREY
- 0.65
IPWR
CBAT
- 0.62
MVST

Risk-Adjusted Indicators

There is a big difference between Ozop Pink Sheet performing well and Ozop Surgical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Ozop Surgical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
PLUG  4.53  0.17  0.00 (0.30) 5.69 
(5.11)
 9.94 
(6.91)
 41.92 
BE  4.46  1.45  0.38  5.44  2.88 
(6.07)
 7.90 
(4.95)
 62.65 
MVST  12.52  4.24  0.54  1.99  5.60 
(24.86)
 13.56 
(10.71)
 358.33 
SLDP  2.43 (0.54) 0.00 (0.24) 0.00 
 0.00 
 5.45 
(6.19)
 19.18 
CBAT  3.03 (0.08) 0.00 (0.08) 0.00 
 0.00 
 6.38 
(5.61)
 28.56 
PPSI  2.67  0.51  0.13  2.65  2.45 
(3.26)
 8.48 
(4.82)
 23.15 
OPTT  4.76  0.71  0.08  0.46  4.71 
(14.07)
 11.11 
(10.00)
 55.58 
IPWR  2.65 (0.46) 0.00 (0.34) 0.00 
 0.00 
 3.96 
(4.95)
 22.65 
XPON  9.66 (0.89) 0.00 (1.84) 0.00 
 0.00 
 29.64 
(24.64)
 74.33 
FREY  5.57  0.36  0.19  0.17  4.87 
(6.93)
 13.17 
(8.98)
 79.43 
All Fundamental Data

Ozop Surgical Competitive Analysis

The better you understand Ozop Surgical competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Ozop Surgical's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Ozop Surgical's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
OZSC PLUG BE MVST SLDP CBAT PPSI OPTT IPWR XPON
 11.11 
 0.0008 
Ozop
 2.90 
 2.13 
Plug
 3.97 
 27.21 
Bloom
 12.00 
 0.84 
Microvast
 0.90 
 1.12 
Solid
 5.56 
 0.95 
CBAK
 1.19 
 5.97 
Pioneer
 27.10 
 0.37 
Ocean
 2.27 
 6.02 
Ideal
 2.64 
 2.33 
Expion360
Market Volatility
(90 Days Market Risk)
Out of control
Dangerous
Somewhat reliable
Out of control
Dangerous
Extremely Dangerous
Relatively risky
Out of control
Slightly risky
Abnormally volatile
Market Performance
(90 Days Performance)
Very Weak
Insignificant
Good
OK
Very Weak
Very Weak
Good
OK
Very Weak
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Low
Above Average
Below Average
Average
Low
Below Average
Low
Quite High
About Average
Very High
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Over Valued
Under Valued
Over Valued
Over Valued
Over Valued
Over Valued
Under Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Buy
Buy
Buy
Hold
Not Available
Strong Buy
Not Available
Strong Buy
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Cautious Hold
Cautious Hold
Strong Hold
Hold
Strong Buy
Strong Hold
Strong Hold
Strong Hold
Strong Buy
Strong Buy
Current Ratio
0.26
6.09
2.46
2.7
36.06
1.09
1.98
16.79
35.32
12.73
Net Asset
11.57 M
4.9 B
2.41 B
1.1 B
532.79 M
281.16 M
33.02 M
28.7 M
12.25 M
11.91 M
Profit Margin
0.45
-2.14
-0.1
-0.31
N/A
0.0789
-0.2
N/A
N/A
-1.68
EBITDA
(141.61 M)
(1.26 B)
(135.13 M)
(80.85 M)
(52.72 M)
10.15 M
617 K
(28.24 M)
(10.08 M)
(7.12 M)
Operating Margin
-0.32
-1.22
-0.0292
0.071
-5.93
0.12
-0.36
-3.44
N/A
-1.31
Current Valuation
41.18 M
2.84 B
7.18 B
439.5 M
77.03 M
87.72 M
66.64 M
20.34 M
32.04 M
5.75 M
Price To Book
38.0
0.66
13.88
0.47
0.46
0.62
4.49
1.01
2.48
0.82
Retained Earnings
N/A
(4.49 B)
(3.87 B)
(891.47 M)
(84.64 M)
(134.4 M)
(19.63 M)
(307.58 M)
(97.05 M)
(21.1 M)
Current Asset
N/A
131.23 M
523.83 M
N/A
N/A
61 K
34.87 M
9.76 M
16.84 M
N/A
Beta
-4.75
1.81
2.71
1.72
1.75
1.9
0.65
2.19
1.09
0.26
Number Of Employees
21
3.87 K
2.38 K
2.01 K
270
1.46 K
143
43
11
23
Shares Outstanding
4.82 B
911.2 M
228.58 M
322.13 M
180.39 M
89.94 M
11.01 M
126.23 M
8.15 M
918.72 K
Cash Flow From Operations
(6.37 M)
(1.11 B)
(372.53 M)
(75.3 M)
(58.26 M)
46.51 M
(3.9 M)
(29.76 M)
(7.13 M)
(5.53 M)
Total Debt
389.42 K
968.85 M
1.45 B
202.77 M
9.55 M
35.74 M
18.8 M
2.57 M
202.99 K
5.96 M
Return On Equity
N/A
-0.43
-0.27
-0.21
-0.18
0.1
-0.41
-0.82
-0.57
-1.53
Z Score
22.6
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return On Asset
-0.38
-0.13
-0.0189
-0.0305
-0.13
0.0533
-0.14
-0.44
-0.34
-0.43
Book Value Per Share
-0.005
3.44
1.89
1.57
2.45
1.25
1.43
0.23
1.68
77.28
Number Of Shares Shorted
N/A
224.23 M
45.83 M
13.95 M
15.9 M
1.12 M
194.23 K
3.98 M
29 K
405.3 K
Current Liabilities
N/A
42.71 M
314.74 M
N/A
N/A
1.33 M
38.1 M
6.17 M
2.58 M
N/A
Total Asset
11.57 M
4.9 B
2.41 B
1.1 B
532.79 M
281.16 M
33.02 M
28.7 M
12.25 M
11.91 M
Debt To Equity
0.35
0.21
2.63
0.27
0.014
0.13
0.14
0.012
0.014
0.36
Short Ratio
N/A
5.72
4.73
2.1
8.9
3.4
1.37
1.33
1.88
0.1
Target Price
N/A
2.73
19.69
4.0
2.0
2.0
10.5
6.0
14.0
4.0
Shares Owned By Institutions
N/A
48.33
83.39
13.4
27.09
2.28
8.07
11.66
30.91
5.08
Market Capitalization
39.78 M
1.89 B
5.98 B
240.08 M
200.23 M
85.54 M
64.97 M
36.85 M
50.19 M
2.09 M
Price To Earning
0.6
-5.2
-1.97
N/A
27.39
3.38
268.67
-0.59
-1.88
N/A
Price To Earnings To Growth
N/A
-0.27
3.17
N/A
N/A
N/A
1.96
N/A
-0.09
N/A
Price To Sales
1.37
2.86
4.75
0.65
11.11
0.38
1.88
6.63
350.71
0.42
Net Income
(195.3 M)
(1.37 B)
(307.94 M)
(106.34 M)
(65.55 M)
(2.45 M)
(1.9 M)
(27.48 M)
(9.95 M)
(7.46 M)
Earnings Per Share
0.01
-2.11
-0.54
-0.36
-0.48
0.12
-0.87
-0.4
-1.38
-7894.38
Shares Owned By Insiders
N/A
6.61
13.18
40.27
22.54
19.83
22.2
2.89
2.95
12.93
Revenue
11.93 M
891.34 M
1.33 B
306.62 M
17.41 M
204.44 M
40.8 M
5.53 M
198.87 K
5.98 M
Working Capital
N/A
822.16 M
1.22 B
292.66 M
167.24 M
(32.07 M)
9.42 M
3.18 M
16.45 M
4.25 M
Cash And Equivalents
1.95 M
2.7 B
348.5 M
333.87 M
484.3 M
4.46 M
9.79 M
51.9 M
20.02 M
8.12 M
Cash Per Share
N/A
4.63
2.52
1.11
2.78
0.05
1.01
0.94
3.39
1.19
Gross Profit
1.59 M
(167.56 M)
257.59 M
9.07 M
2.2 M
18.1 M
1.39 M
(101 K)
N/A
1.65 M
Day Typical Price
8.0E-4
2.17
27.58
0.82
1.13
0.96
5.93
0.36
6.15
2.33
Accumulation Distribution
0.22
5.2 M
786174.0
2.2 M
54206.74
8914.87
2853.42
69 M
1177.57
4855.93
Market Facilitation Index
2.0E-4
N/A
N/A
N/A
N/A
N/A
0.0
N/A
0.0
0.0
Daily Balance Of Power
(0.50)
0.2727
0.5562
0.6429
0.1667
1.25
0.3333
0.5614
(0.33)
0.5
Period Momentum Indicator
(0.0001)
0.06
1.04
0.09
0.01
0.05
0.07
0.0786
(0.14)
0.06
Rate Of Daily Change
0.89
1.03
1.04
1.12
1.01
1.06
1.01
1.27
0.98
1.03
Day Median Price
8.0E-4
2.19
27.77
0.81
1.13
0.97
5.91
0.36
6.21
2.33
Price Action Indicator
(0.00005)
(0.03)
(0.04)
0.075
(0.01)
0.005
0.09
0.0479
(0.26)
0.03
Relative Strength Index
55.26
30.4
63.94
19.02
47.23
51.21
89.44
14.28
32.12
47.35
Coefficient Of Variation
(2,294)
4671.25
576.79
954.26
(964.35)
(21,021)
714.1
1023.7
(1,163)
(1,751)
Mean Deviation
4.96
4.53
4.46
12.52
2.43
3.03
2.67
4.76
2.65
9.66
Jensen Alpha
(0.12)
0.1718
1.45
4.24
(0.54)
(0.08)
0.5067
0.7145
(0.46)
(0.89)
Total Risk Alpha
(1.54)
(0.85)
0.127
(2.28)
(0.89)
(0.70)
(0.08)
(0.61)
(0.95)
(3.12)
Sortino Ratio
N/A
4.0E-4
0.3811
0.536
N/A
N/A
0.1333
0.0802
N/A
N/A
Downside Variance
N/A
37.91
12.87
67.07
N/A
N/A
9.47
111.89
N/A
N/A
Standard Deviation
7.61
6.2
8.64
43.13
3.36
4.26
3.86
10.02
3.85
14.48
Kurtosis
1.72
2.66
31.26
61.95
1.61
4.26
3.64
21.06
5.81
3.08
Potential Upside
11.11
9.94
7.9
13.56
5.45
6.38
8.48
11.11
3.96
29.64
Treynor Ratio
0.1891
(0.30)
5.44
1.99
(0.24)
(0.08)
2.65
0.4586
(0.34)
(1.84)
Maximum Drawdown
38.38
41.92
62.65
358.33
19.18
28.56
23.15
55.58
22.65
74.33
Variance
57.86
38.43
74.62
1860.43
11.29
18.12
14.91
100.42
14.85
209.64
Market Risk Adjusted Performance
0.1991
(0.29)
5.45
2.0
(0.23)
(0.07)
2.66
0.4686
(0.33)
(1.83)
Risk Adjusted Performance
(0.02)
0.0251
0.1417
0.0899
(0.07)
0.0046
0.1151
0.0839
(0.06)
(0.03)
Skewness
0.5592
0.0889
4.9
7.76
0.3185
0.9322
1.32
3.57
0.2355
1.22
Semi Deviation
N/A
5.69
2.88
5.6
N/A
N/A
2.45
4.71
N/A
N/A
Information Ratio
(0.06)
4.0E-4
0.1583
0.1018
(0.14)
(0.04)
0.1063
0.0847
(0.12)
(0.07)
Value At Risk
(11.11)
(6.91)
(4.95)
(10.71)
(6.19)
(5.61)
(4.82)
(10.00)
(4.95)
(24.64)
Expected Short fall
N/A
(5.11)
(6.07)
(24.86)
N/A
N/A
(3.26)
(14.07)
N/A
N/A
Downside Deviation
N/A
6.16
3.59
8.19
N/A
N/A
3.08
10.58
N/A
N/A
Semi Variance
N/A
32.36
8.31
31.4
N/A
N/A
6.02
22.23
N/A
N/A

Ozop Surgical Competition Performance Charts

Five steps to successful analysis of Ozop Surgical Competition

Ozop Surgical's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Ozop Surgical Corp in relation to its competition. Ozop Surgical's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Ozop Surgical in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Ozop Surgical's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Ozop Surgical Corp, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Ozop Surgical position

In addition to having Ozop Surgical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Aluminum Thematic Idea Now

Aluminum
Aluminum Theme
Companies involved in production of aluminum. The Aluminum theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Aluminum Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Ozop Pink Sheet

Ozop Surgical financial ratios help investors to determine whether Ozop Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ozop with respect to the benefits of owning Ozop Surgical security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY